All Stories

  1. Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial–Mesenchymal Transition, and Invasion

    Article • Brain Sciences, January 2024, MDPI AG

    Andrew Morokoff

  2. Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma

    Article • Neuro-Oncology Advances, January 2024, Oxford University Press (OUP)

    Andrew Morokoff

  3. Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in glioma

    Article • Neuro-Oncology Advances, January 2024, Oxford University Press (OUP)

    Andrew Morokoff

  4. An In Vitro Brain Tumour Model in Organotypic Slice Cultures Displaying Epileptiform Activity

    Article • Brain Sciences, October 2023, MDPI AG

    Andrew Morokoff

  5. Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner

    Article • Cellular Oncology, April 2023, Springer Science + Business Media

    Andrew Morokoff

  6. Spatial architecture of high-grade glioma reveals tumor heterogeneity within distinct domains

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Andrew Morokoff

  7. The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Andrew Morokoff

  8. Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

    Article • Molecular and Cellular Biochemistry, October 2022, Springer Science + Business Media

    Andrew Morokoff

  9. Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression

    Article • International Journal of Molecular Sciences, March 2022, MDPI AG

    Andrew Morokoff

  10. Serum microRNA is a biomarker for post-operative monitoring in glioma

    Article • Journal of Neuro-Oncology, September 2020, Springer Science + Business Media

    Andrew Morokoff

  11. Correction to: Serum microRNA is a biomarker for post-operative monitoring in glioma

    Article • Journal of Neuro-Oncology, September 2020, Springer Science + Business Media

    Andrew Morokoff

  12. Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma

    Article • Cancer Investigation, March 2019, Taylor & Francis

    Andrew Morokoff, Dr Stanley S Stylli, Adam McCluskey

  13. Early seizures and temporal lobe trauma predict post-traumatic epilepsy: A longitudinal study

    Article • Neurobiology of Disease, March 2019, Elsevier

    Andrew Morokoff

  14. The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol

    Article • Neurobiology of Disease, March 2019, Elsevier

    Andrew Morokoff

  15. Metabolic patterns and seizure outcomes following anterior temporal lobectomy

    Article • Annals of Neurology, January 2019, Wiley

    Andrew Morokoff

  16. Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance

    Article • Experimental Cell Research, January 2019, Elsevier

    Andrew Morokoff

  17. Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs

    Article • Translational Oncology, December 2018, Elsevier

    Andrew Morokoff

  18. VDAC2 enables BAX to mediate apoptosis and limit tumor development

    Article • Nature Communications, November 2018, Springer Science + Business Media

    Dr Andre L Samson, Andrew Morokoff

  19. Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide

    Article • Journal of Neurosurgery, September 2018, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr Stanley S Stylli, Andrew Morokoff

  20. The role of interleukin‑6‑STAT3 signalling in glioblastoma (Review)

    Article • Oncology Letters, July 2018, Spandidos Publications

    Andrew Morokoff

  21. A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker

    Article • PLOS One, February 2018, PLOS

    Andrew Morokoff

  22. First line direct access for transarterial embolization of a dural arteriovenous fistula: Case report and literature review

    Article • Journal of Clinical Neuroscience, February 2018, Elsevier

    Andrew Morokoff

  23. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy

    Article • Epilepsy & Behavior, January 2018, Elsevier

    Andrew Morokoff

  24. Cancer exosomes in cerebrospinal fluid

    Article • Translational Cancer Research, October 2017, AME Publishing Company

    Andrew Morokoff

  25. Post-operative seizure prophylaxis in gliomas

    Article • Translational Cancer Research, August 2017, AME Publishing Company

    Andrew Morokoff

  26. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity

    Article • PLOS One, February 2017, PLOS

    Andrew Morokoff

  27. The emergent role of exosomes in glioma

    Article • Journal of Clinical Neuroscience, January 2017, Elsevier

    Andrew Morokoff

  28. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin

    Article • Journal of Neuro-Oncology, November 2016, Springer Science + Business Media

    Andrew Morokoff

  29. Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab

    Article • Journal of Neurosurgery, October 2016, Journal of Neurosurgery Publishing Group (JNSPG)

    Prof. Tali Siegal, Prof. Arriel Benis, Andrew Morokoff

  30. Postoperative seizure control in patients with tumor-associated epilepsy

    Article • Epilepsia, September 2016, Wiley

    Andrew Morokoff

  31. Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit

    Article • Neurosurgery, July 2016, Oxford University Press (OUP)

    Andrew Morokoff

  32. Peritumoural glutamate correlates with post-operative seizures in supratentorial gliomas

    Article • Journal of Neuro-Oncology, June 2016, Springer Science + Business Media

    Andrew Morokoff

  33. Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib

    Article • Medical Oncology, April 2016, Springer Science + Business Media

    Andrew Morokoff

  34. Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme

    Article • Journal of Clinical Neuroscience, November 2015, Elsevier

    Andrew Morokoff

  35. MicroRNA as potential biomarkers in Glioblastoma

    Article • Journal of Neuro-Oncology, September 2015, Springer Science + Business Media

    Andrew Morokoff

  36. Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma

    Article • Journal of Clinical Neuroscience, August 2015, Elsevier

    Andrew Morokoff

  37. Large suprasellar mass: answer

    Article • Journal of Clinical Neuroscience, July 2015, Elsevier

    Andrew Morokoff

  38. Large suprasellar mass: question

    Article • Journal of Clinical Neuroscience, July 2015, Elsevier

    Andrew Morokoff

  39. Occult temporal lobe encephalocoele into the transverse sinus

    Article • Journal of Clinical Neuroscience, July 2015, Elsevier

    Andrew Morokoff

  40. A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: Increasing glutamate uptake with PPARγ agonists

    Article • Journal of Clinical Neuroscience, January 2015, Elsevier

    Andrew Morokoff

  41. In response: IDH1 mutation expression is associated with seizures and protoplasmic subtype in patients with low‐grade glioma

    Article • Epilepsia, October 2014, Wiley

    Andrew Morokoff

  42. The Continuing Evolution

    Article • Neurosurgery, August 2014, Oxford University Press (OUP)

    Andrew Morokoff

  43. IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low‐grade gliomas

    Article • Epilepsia, June 2014, Wiley

    Andrew Morokoff

  44. Complexities of lysophospholipid signalling in glioblastoma

    Article • Journal of Clinical Neuroscience, June 2014, Elsevier

    Andrew Morokoff

  45. Tumour associated epilepsy and glutamate excitotoxicity in patients with gliomas

    Article • Journal of Clinical Neuroscience, June 2014, Elsevier

    Andrew Morokoff

  46. Glutamate quantification in patients with supratentorial gliomas using chemical shift imaging

    Article • NMR in Biomedicine, March 2014, Wiley

    Andrew Morokoff

  47. Implementing evidence-based recommended practices for the management of patients with mild traumatic brain injuries in Australian emergency care departments: study protocol for a cluster randomised controlled trial

    Article • Trials, January 2014, Springer Science + Business Media

    Andrew Morokoff

  48. Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study

    Article • The Lancet Neurology, June 2013, Elsevier

    Andrew Morokoff

  49. Resective Surgery of Temporal Lobe Epilepsy

    Article • December 2012, Oxford University Press (OUP)

    Andrew Morokoff

  50. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas

    Article • Journal of Clinical Neuroscience, November 2012, Elsevier

    Andrew Morokoff

  51. Glutamate is associated with a higher risk of seizures in patients with gliomas

    Article • Neurology, July 2012, Wolters Kluwer Health

    Andrew Morokoff

  52. Carcinoma of the paranasal sinuses

    Article • January 2012, Elsevier

    Andrew Morokoff

  53. Acoustic neurinoma (vestibular schwannoma)

    Article • January 2012, Elsevier

    Andrew Morokoff

  54. Epilepsy associated with brain tumors

    Article • January 2012, Elsevier

    Andrew Morokoff

  55. Inhibition of Dynamin by Dynole 34-2 Induces Cell Death following Cytokinesis Failure in Cancer Cells

    Article • Molecular Cancer Therapeutics, July 2011, American Association for Cancer Research (AACR)

    Andrew Morokoff, Christopher Gordon

  56. An unusual cause of skull and cervical spine masses

    Article • Journal of Clinical Neuroscience, July 2011, Elsevier

    Andrew Morokoff

  57. Spontaneous spinal epidural haematoma in a geriatric patient on aspirin

    Article • Journal of Clinical Neuroscience, January 2010, Elsevier

    Andrew Morokoff

  58. Spinal cord compression as the initial presentation of acute biphenotypic leukaemia

    Article • Journal of Clinical Neuroscience, December 2009, Elsevier

    Andrew Morokoff

  59. Surgery for Convexity Meningiomas

    Article • Neurosurgery, September 2008, Oxford University Press (OUP)

    Andrew Morokoff

  60. SURGERY FOR EXTRA-AXIAL TUMORS OF THE CEREBRAL CONVEXITY AND MIDLINE

    Article • Neurosurgery, June 2008, Oxford University Press (OUP)

    Andrew Morokoff

  61. SURGERY FOR EXTRA‐AXIAL TUMORS OF THE CEREBRAL CONVEXITY AND MIDLINE

    Article • Neurosurgery, June 2008, Wolters Kluwer Health

    Andrew Morokoff

  62. Diffuse choroid plexus hyperplasia: an under-diagnosed cause of hydrocephalus in children?

    Article • Pediatric Radiology, April 2005, Springer Science + Business Media

    Andrew Morokoff

  63. Targeted therapy for malignant gliomas

    Article • Journal of Clinical Neuroscience, November 2004, Elsevier

    Andrew Morokoff

  64. Idiopathic spinal cord herniation

    Article • Journal of Clinical Neuroscience, March 2001, Elsevier

    Andrew Morokoff

  65. Epidemiology and Aetiological Factors

    Article • Springer Science + Business Media

    Andrew Morokoff